Retrospective cohort data from the USA suggest that, compared to White individuals with type 2 diabetes, Asian, Black and Hispanic individuals were less likely to receive GLP-1 RA therapy [21]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.